These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12397766)

  • 21. Additive therapeutic effects of the liver extract preparation mixture adelavin-9 on interferon-beta treatment for chronic hepatitis C.
    Ebinuma H; Saito H; Tada S; Masuda T; Kamiya T; Nishida J; Yoshioka M; Ishii H;
    Hepatogastroenterology; 2004; 51(58):1109-14. PubMed ID: 15239256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection.
    Muir AJ; Sylvestre PB; Rockey DC
    J Viral Hepat; 2006 May; 13(5):322-8. PubMed ID: 16637863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Successful treatment of chronic hepatitis C in hemophiliacs based on historical development of therapeutic protocols].
    Husa P; Smejkal P; Husová L; Chalupa P; Penka M
    Vnitr Lek; 2004 Jan; 50(1):30-5. PubMed ID: 15015227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interferon-alpha and ribavirin combination therapy for co-infection of hepatitis C virus and human immunodeficiency virus].
    Zheng YH; He Y; Yang X; Gong GZ; Zhou HY; Zhang CY; Zhou W; Huang L; Ding PP; Li H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):741-4. PubMed ID: 16248945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hepatitis C virus infection in thalassemia.
    Butensky E; Pakbaz Z; Foote D; Walters MC; Vichinsky EP; Harmatz P
    Ann N Y Acad Sci; 2005; 1054():290-9. PubMed ID: 16339677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C.
    Xu DZ; Xie Y; Li ZQ
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):550-3. PubMed ID: 16286260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type C-chronic hepatitis patients who had autoimmune phenomenon and developed jaundice during interferon therapy.
    Sezaki H; Arase Y; Tsubota A; Suzuki Y; Kobayashi M; Saitoh S; Suzuki F; Akuta N; Someya T; Ikeda K; Kumada H
    J Gastroenterol; 2003; 38(5):493-500. PubMed ID: 12768394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.
    Hoofnagle JH; Ghany MG; Kleiner DE; Doo E; Heller T; Promrat K; Ong J; Khokhar F; Soza A; Herion D; Park Y; Everhart JE; Liang TJ
    Hepatology; 2003 Jul; 38(1):66-74. PubMed ID: 12829988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy.
    Arase Y; Ikeda K; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Suzuki F; Akuta N; Someya T; Hosaka T; Kobayashi M; Kumada H
    J Gastroenterol; 2004; 39(5):455-60. PubMed ID: 15175944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: sustained response in two patients with transfusion dependent thalassaemia.
    Hamidah A; Yong JF; Zulkifli HI; Jamal R
    Med J Malaysia; 2002 Sep; 57(3):353-6. PubMed ID: 12440276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful application of highly purified natural interferon alpha (multiferon) in a chronic hepatitis C patient resistant to preceding treatment approaches.
    Musch E; Malek M; von Eick H; Chrissafidou A
    Hepatogastroenterology; 2004; 51(59):1476-9. PubMed ID: 15362781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumefactive multiple sclerosis and hepatitis C virus 2a/2C infection: Dual benefit of long-term interferon beta-1a therapy?
    Mader EC; Richeh W; Ochoa JM; Sullivan LL; Gutierrez AN; Lovera JF
    J Neurol Sci; 2015 Feb; 349(1-2):239-42. PubMed ID: 25575859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [About the article: "Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis" by Jacobs LD et al].
    Labetouelle M
    J Fr Ophtalmol; 2001 Feb; 24(2):222. PubMed ID: 11332406
    [No Abstract]   [Full Text] [Related]  

  • 34. [Interferon-beta retinopathy].
    Sallansonnet-Froment M; Roux X; de Greslan T; Bounolleau P; Taillia H; Ricard D; Ouologuem M; Renard JL
    Rev Neurol (Paris); 2009 Nov; 165(11):971-4. PubMed ID: 19147167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of septal panniculitis secondary to interferon treatment.
    Ozuguz P; Kacar SD; Karaca S; Tokyol C
    Cutan Ocul Toxicol; 2014 Dec; 33(4):351-2. PubMed ID: 24641120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Local cutaneous necrosis after injection of interferon beta].
    Bérard F; Canillot S; Balme B; Perrot H
    Ann Dermatol Venereol; 1995; 122(3):105-7. PubMed ID: 7486717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Absence of antiviral activity of high-dose subcutaneous beta-interferon in patients with chronic infection by genotype 1 virus C hepatitis].
    Jiménez Sáenz M; Carmona Soria I; Caunedo Alvarez A; González Vílchez J
    Med Clin (Barc); 2000 May; 114(18):717. PubMed ID: 10916795
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tubercular granulomas of the liver in a Somalian patient notwithstanding a chronic hepatitis C].
    Vreede RW; Bolwerk CJ; Eulderink F; Bac DJ
    Ned Tijdschr Geneeskd; 2001 Mar; 145(11):535-8. PubMed ID: 11284289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Crohn's disease during the course of multiple sclerosis: role of interferon-beta therapy].
    Samson M; Audia S; Duchêne C; Perinet I; Bielefeld P; Besancenot JF
    Rev Med Interne; 2009 Sep; 30(9):816-9. PubMed ID: 19201069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurosarcoidosis associated with interferon therapy.
    Miwa H; Furuya T; Tanaka S; Mizuno Y
    Eur Neurol; 2001; 45(4):288-9. PubMed ID: 11385273
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.